Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study
Clinical trial NCT07523971 · RECRUITING
Trial details
- NCT number
- NCT07523971
- Sponsor
- JW Pharmaceutical
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-25
- Primary completion
- 2026-12-01
- Enrollment
- 10000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.